Inhibitory effect of Lovastatin on spontaneous metastases derived from a rat lymphoma

Abstract
The HMGCoA reductase inhibitor Lovastatin (LOV) has previously shown to abrogate p21ras farnesylation, which is associated with invasive and metastatic abilities in many tumor models. Considering the...